Drug reference
temsirolimus
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Oncology (TK Inhibitors)
Mechanism of action
Kinase inhibitor, converted to its active metabolite sirolimus that inhibits mTOR (mammalian target of rapamycin) which in turn may reduce activity/levels of several growth factors and kinases
Common side effects
- Decreased hemoglobin
- Hyperglycemia
- Hypertriglyceridemia
- Hypercholesterolemia
- Increased alkaline phosphatase
- Increased serum creatinine
- Decreased lymphocyte count
Known interactions (1)
Related conditions
Frequently asked questions
What drug class is temsirolimus?
temsirolimus belongs to: Oncology.
How does temsirolimus work?
Kinase inhibitor, converted to its active metabolite sirolimus that inhibits mTOR (mammalian target of rapamycin) which in turn may reduce activity/levels of several growth factors and kinases
What are the common side effects of temsirolimus?
Decreased hemoglobin, Hyperglycemia, Hypertriglyceridemia, Hypercholesterolemia, Increased alkaline phosphatase, Increased serum creatinine, Decreased lymphocyte count
Which drugs interact with temsirolimus?
hepatitis a vaccine inactivated
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.